日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Burden of illness among patients with asthma prescribed inhaled corticosteroids/long-acting β(2)-agonists

使用吸入性皮质类固醇/长效β2受体激动剂治疗哮喘患者的疾病负担

期刊:npj Primary Care Respiratory Medicine
影响因子:4.7
doi:10.1038/s41533-024-00402-w
Zhang, Shiyuan; Czira, Alexandrosz; Harley, Julia; Rothnie, Kieran J; Lee, Lauren; Small, Mark
信号转导
哮喘
发表日期：2025
文献求助 收藏

Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study

更正：在英格兰慢性阻塞性肺疾病急性加重期患者中及时启动单吸入器氟替卡松糠酸酯、乌美溴铵和维兰特罗（FF/UMEC/VI）治疗的益处：一项回顾性队列研究

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-024-02745-x
Ismaila, Afisi S; Rothnie, Kieran J; Wood, Robert P; Banks, Victoria L; Camidge, Lucinda J; Czira, Alexandrosz; Compton, Chris; Sharma, Raj; Millard, Shannon N; Massey, Olivia; Halpin, David M G
慢性阻塞性肺疾病
发表日期：2024
文献求助 收藏

Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy

美国新近开始使用多种吸入器三联疗法的哮喘患者的特征、治疗模式和疾病负担

期刊:Bmj Open Respiratory Research
影响因子:3.4
doi:10.1136/bmjresp-2023-001702
Numbere, Beade; Liu, Yunhao; Zhang, Shiyuan; Czira, Alexandrosz; Lu, Yifei
哮喘
发表日期：2024
文献求助 收藏

Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study

在英国真实世界的基层医疗机构中，慢性阻塞性肺疾病患者从多吸入器疗法转换为每日一次单吸入器三联疗法后的疗效：一项回顾性前后队列研究

期刊:Bmj Open Respiratory Research
影响因子:3.4
doi:10.1136/bmjresp-2023-001890
Rothnie, Kieran J; Wood, Robert P; Czira, Alexandrosz; Banks, Victoria L; Camidge, Lucinda J; Massey, Olivia K I; Seif, Monica; Compton, Chris; Sharma, Raj; Halpin, David M G; Ismaila, Afisi S; Vogelmeier, Claus F
慢性阻塞性肺疾病
发表日期：2024
文献求助 收藏

Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany

德国慢性阻塞性肺疾病单吸入器和多吸入器三联疗法用户及新启动者的特征

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S431291
Beeh, Kai-Michael; Rothnie, Kieran J; Claussen, Jing; Hardtstock, Fränce; Knapp, Rachel K; Wilke, Thomas; Czira, Alexandrosz; Compton, Chris; Ismaila, Afisi S
慢性阻塞性肺疾病
发表日期：2024
文献求助 收藏

Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study

英格兰基层医疗机构中慢性阻塞性肺疾病患者吸入糖皮质激素/长效β2受体激动剂双重疗法的治疗路径、经济负担和临床结局：一项回顾性队列研究

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-072361
Czira, Alexandrosz; Banks, Victoria; Requena, Gema; Wood, Robert; Tritton, Theo; Wild, Rosie; Compton, Chris; Ismaila, Afisi
信号转导
慢性阻塞性肺疾病
免疫/内分泌
发表日期：2024
文献求助 收藏

Comparative adherence and persistence of single-inhaler and multiple-inhaler triple therapies among patients with chronic obstructive pulmonary disease in Japan: a retrospective cohort study

日本慢性阻塞性肺疾病患者单吸入器三联疗法与多吸入器三联疗法依从性和持续性的比较：一项回顾性队列研究

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-080864
Jokšaitė, Sandra; Wood, Robert; Ismaila, Afisi; Camidge, Lucinda; Mizukami, Akiko; Czira, Alexandrosz; Massey, Olivia; Yarita, Masao; Compton, Chris; Siddiqui, Rad; Jennison, Thomas; Ishii, Takeo; Hashimoto, Kenichi; Rothnie, Kieran J
慢性阻塞性肺疾病
发表日期：2024
文献求助 收藏

Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study

在英国，慢性阻塞性肺疾病急性加重期患者及时使用单吸入剂氟替卡松糠酸酯、乌美溴铵和维兰特罗（FF/UMEC/VI）的益处：一项回顾性队列研究

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-023-02523-1
Ismaila, Afisi S; Rothnie, Kieran J; Wood, Robert P; Banks, Victoria L; Camidge, Lucinda J; Czira, Alexandrosz; Compton, Chris; Sharma, Raj; Millard, Shannon N; Massey, Olivia; Halpin, David M G
慢性阻塞性肺疾病
发表日期：2023
文献求助 收藏

Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England

在英国基层医疗机构中，乌美溴铵/维兰特罗与吸入性皮质类固醇/长效β2受体激动剂治疗慢性阻塞性肺疾病患者的疗效比较

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S405498
Czira, Alexandrosz; Requena, Gema; Banks, Victoria; Wood, Robert; Tritton, Theo; Castillo, Catherine M; Yeap, Jie; Wild, Rosie; Compton, Chris; Rothnie, Kieran J; Herth, Felix; Quint, Jennifer K; Ismaila, Afisi S
信号转导
慢性阻塞性肺疾病
发表日期：2023
文献求助 收藏

Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England

在英国常规临床实践中，对接受乌美溴铵/维兰特罗与噻托溴铵/奥洛达特罗治疗的慢性阻塞性肺疾病患者的急救药物处方进行比较

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S411437
Requena, Gema; Czira, Alexandrosz; Banks, Victoria; Wood, Robert; Tritton, Theo; Castillo, Catherine M; Yeap, Jie; Wild, Rosie; Compton, Chris; Rothnie, Kieran J; Herth, Felix; Quint, Jennifer K; Ismaila, Afisi S
慢性阻塞性肺疾病
发表日期：2023
文献求助 收藏